Literature DB >> 21528070

An overview of occult hepatitis B virus infection.

Zeinab Nabil Ahmed Said.   

Abstract

Occult hepatitis B virus (HBV) infection (OBI), alternatively defined as occult hepatitis B (OHB), is a challenging clinical entity. It is recognized by two main characteristics: absence of HBsAg, and low viral replication. The previous two decades have witnessed a remarkable progress in our understanding of OBI and its clinical implications. Appropriate diagnostic techniques must be adopted. Sensitive HBV DNA amplification assay is the gold standard assay for detection of OBI. Viral as well as host factors are implicated in the pathogenesis of OBI. However, published data reporting the infectivity of OBI by transfusion are limited. Several aspects including OBI transmission, infectivity and its relation to the development of chronic liver diseases and hepatocellular carcinoma have to be resolved. The aim of the present review is to highlight recent data on OBI with a focus on its virological diagnosis and clinical outcome.

Entities:  

Keywords:  Chronic liver disease; Hepatitis B surface antigen; Hepatitis B virus; Hepatocellular carcinoma; Occult hepatitis B; Occult hepatitis B virus infection; Occult infection

Mesh:

Year:  2011        PMID: 21528070      PMCID: PMC3082745          DOI: 10.3748/wjg.v17.i15.1927

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  114 in total

1.  Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening.

Authors:  Steven H Kleinman; Mary C Kuhns; Deborah S Todd; Simone A Glynn; Anne McNamara; Anthony DiMarco; Michael P Busch
Journal:  Transfusion       Date:  2003-06       Impact factor: 3.157

2.  Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection.

Authors:  Robin Biswas; Edward Tabor; Chu Chieh Hsia; David J Wright; Megan E Laycock; Eberhard W Fiebig; Lorraine Peddada; Richard Smith; George B Schreiber; Jay S Epstein; George J Nemo; Michael P Busch
Journal:  Transfusion       Date:  2003-06       Impact factor: 3.157

Review 3.  The German experience with NAT.

Authors:  W K Roth; E Seifried
Journal:  Transfus Med       Date:  2002-08       Impact factor: 2.019

4.  Transfusion-transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers.

Authors:  Jin-Town Wang; Cha-Ze Lee; Pei-Jer Chen; Teh-Hong Wang; Ding-Shinn Chen
Journal:  Transfusion       Date:  2002-12       Impact factor: 3.157

5.  Transfusion-transmitted hepatitis B virus infection in the UK: a small and moving target.

Authors:  K Soldan; J A J Barbara; B C Dow
Journal:  Vox Sang       Date:  2002-11       Impact factor: 2.144

6.  Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen.

Authors:  Holger Hennig; Ines Puchta; Jürgen Luhm; Peter Schlenke; Siegfried Goerg; Holger Kirchner
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

7.  HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis.

Authors:  Bruno Roche; Cyrille Feray; Michele Gigou; Anne Marie Roque-Afonso; Jean Louis Arulnaden; Valerie Delvart; Elisabeth Dussaix; Catherine Guettier; Henri Bismuth; Didier Samuel
Journal:  Hepatology       Date:  2003-07       Impact factor: 17.425

8.  The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana.

Authors:  Jean-Pierre Allain; Daniel Candotti; Kate Soldan; Francis Sarkodie; Bruce Phelps; Cristina Giachetti; Venkatakrishna Shyamala; Francis Yeboah; Margaret Anokwa; Shirley Owusu-Ofori; Ohene Opare-Sem
Journal:  Blood       Date:  2002-10-17       Impact factor: 22.113

Review 9.  Occult hepatitis B.

Authors:  Michael Torbenson; David L Thomas
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

Review 10.  Occult hepatitis B virus infection.

Authors:  Jean-Pierre Allain
Journal:  Transfus Clin Biol       Date:  2004-02       Impact factor: 1.406

View more
  55 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 2.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

3.  Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.

Authors:  Abeer Elkady; Sahar Aboulfotuh; Elsayed Mostafa Ali; Douaa Sayed; Nashwa M Abdel-Aziz; Amany M Ali; Shuko Murakami; Sayuki Iijima; Yasuhito Tanaka
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

Review 4.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 5.  Immunopathogenesis of chronic hepatitis B.

Authors:  Irina P Balmasova; Nikolay D Yushchuk; Ospan A Mynbaev; Nageswara R Alla; Elena S Malova; Zhongjie Shi; Chang-Lu Gao
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 6.  Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing.

Authors:  Antonella Esposito; Chiara Sabia; Carmela Iannone; Giovanni F Nicoletti; Linda Sommese; Claudio Napoli
Journal:  Transfus Med Hemother       Date:  2017-05-05       Impact factor: 3.747

7.  KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2012-06-26

8.  Blood-borne viral infections in pediatric hemodialysis.

Authors:  Shina Menon; Raj Munshi
Journal:  Pediatr Nephrol       Date:  2018-07-21       Impact factor: 3.714

9.  Occult hepatitis B virus infection among injecting drug users in the Central-West Region of Brazil.

Authors:  Márcia Alves Dias de Matos; Renata Carneiro Ferreira; Fabiana Perez Rodrigues; Tamíris Augusto Marinho; Carmen Luci Rodrigues Lopes; Antônia Carlos Magalhães Novais; Ana Rita Coimbra Motta-Castro; Sheila Araújo Teles; Francisco José Dutra Souto; Regina Maria Bringel Martins
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

10.  Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

Authors:  Eleanor A Powell; Ceejay L Boyce; Maemu P Gededzha; Selokela G Selabe; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Gen Virol       Date:  2016-03-31       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.